Aspen Pharmacare Free Cash Flow 2017-2023 | APNHY
Aspen Pharmacare annual/quarterly free cash flow history and growth rate from 2017 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Aspen Pharmacare free cash flow for the quarter ending June 30, 2023 was , a year-over-year.
- Aspen Pharmacare free cash flow for the twelve months ending June 30, 2023 was , a year-over-year.
- Aspen Pharmacare annual free cash flow for 2023 was $0.187B, a 17.5% decline from 2022.
- Aspen Pharmacare annual free cash flow for 2022 was $0.226B, a 33.13% decline from 2021.
- Aspen Pharmacare annual free cash flow for 2021 was $0.339B, a 15.57% decline from 2020.
| Aspen Pharmacare Annual Free Cash Flow |
| 2023 |
186.80 |
| 2022 |
226.42 |
| 2021 |
338.58 |
| 2020 |
401.02 |
| 2019 |
251.62 |
| 2018 |
381.83 |
| 2017 |
367.50 |
| 2016 |
104.10 |
| 2015 |
|
| Aspen Pharmacare Quarterly Free Cash Flow |
| 2023-06-30 |
|
| 2022-06-30 |
|
| 2021-12-31 |
|
| 2021-06-30 |
|
| 2020-12-31 |
|
| 2020-06-30 |
|
| 2019-06-30 |
|
| 2018-12-31 |
|
| 2018-06-30 |
|
| 2017-12-31 |
|
| 2017-06-30 |
|
| 2016-12-31 |
|
| 2016-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$5.038B |
$2.296B |
|
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
|
